Endoscopically guided midfacial degloving in infants for removal of congenital and acquired midfacial masses.

Int J Pediatr Otorhinolaryngol

Department of Otolaryngology--Head and Neck Surgery, Walter Reed Army Medical Center, Washington, DC, USA.

Published: December 1998

Midface degloving allows excellent exposure for a variety of congenital and acquired pediatric facial masses. The petite facial skeleton of the infant and child, however, can limit the utility of this dissection, thereby necessitating external approaches and altered cosmesis. Endoscopic assistance can aid in safe and complete removal of these masses without the need for external surgical approaches. In this series, five infants underwent midfacial degloving for midface lesions. Those masses that could not be adequately visualized underwent midfacial degloving with endoscopic assistance. Successful surgical removal was accomplished without complications, with follow-up ranging from 1 to 5 years. No surgical nasal deformity, vestibular stenosis, or decrease in midfacial growth was noted. Midfacial degloving with endoscopic guidance in selected cases is a cosmetically appealing option for lesions not otherwise resectable by standard midface degloving.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-5876(98)00087-1DOI Listing

Publication Analysis

Top Keywords

midfacial degloving
16
congenital acquired
8
midface degloving
8
endoscopic assistance
8
underwent midfacial
8
degloving endoscopic
8
midfacial
6
degloving
6
endoscopically guided
4
guided midfacial
4

Similar Publications

Unlabelled: Extra Nasopharyngeal Angiofibromas are rare benign vascular tumors typically affecting adolescent males. They have variable sites of origin. Only five cases of extra nasopharyngeal angiofibroma originating from the middle turbinate have been reported in the literature, here we present the sixth such case.

View Article and Find Full Text PDF

A man in his 20s presented with complaints of unilateral nasal obstruction for the past 6 years that progressively worsened leading to irrational use of over-the-counter nasal decongestants. With the worsening of symptoms, a non-contrast CT was done. It showed a dense expansile sclerotic lesion of the right inferior turbinate, which was excised endoscopically.

View Article and Find Full Text PDF

Nasal chondromas and nasal atypical cartilaginous tumors (or chondrosarcoma grade 1) are very rare chondrogenic tumors. Approximately 150 cases of nasal chondroma and fewer than 50 cases of nasal atypical cartilaginous tumors have been described. We reported a case with nasal chondroma in the right ethmoid area and a case with a nasal atypical cartilaginous tumor of the anterior septum.

View Article and Find Full Text PDF

Ossifying fibroma is benign, slowly expansile, painless, well defined fibro-osseous tumour composed of calcified products such as bone, cementum, or both [1]. We opted for a novel approach for the management of ossifying fibroma of maxillary region through scarless midfacial degloving approach with iliac bone graft reconstruction. A 20 years old young female presented with left sided facial swelling involving anterior wall of maxilla and lifting the ala of nose.

View Article and Find Full Text PDF

Surgical access to pterygopalatine and infratemporal fossa has always been important for head and neck surgeons to deal with various benign and malignant tumours. Technical advancements leading to advent of microdebrider, coblation instruments and endoscopes, have proved helpful in gaining access to these complex anatomical areas, by way of endoscopic endonasal approaches but availability of instruments and learning curve remains a limiting factor. Thus older open surgical techniques like maxillary swing, Le Fort osteotomies and midfacial degloving still holds their importance in providing direct open access to these areas.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!